Litigation Details for Orexo AB v. Actavis Elizabeth LLC (D. Del. 2017)
✉ Email this page to a colleague
Orexo AB v. Actavis Elizabeth LLC (D. Del. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-02-28 |
| Court | District Court, D. Delaware | Date Terminated | 2019-12-12 |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 6,761,910; 8,454,996; 8,940,330 | ||
| Link to Docket | External link to docket | ||
Details for Orexo AB v. Actavis Elizabeth LLC (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2018-11-09 | 160 | Subutex® infringe United States Patent No. 8,454,996 ("the #996 patent"). In an earlier case filed…Robinson also held that U.S. Patent No. 8,940,330 ("the #330 patent") was invalid as obvious…the #330 patent does not implicate Judge Robinson's rulings with respect to the #996 patent. … generic version of Zubsolv® infringed the #996 patent. Orexo AB v. Actavis Elizabeth LLC, 217 F. Supp…Robinson ruled among other things that the #996 patent was valid and infringed by Actavis Elizabeth LLC | External link to document | |
| 2019-01-04 | 189 | Defendants’2 products infringe U.S. Patent 8,454,996 (“the ’996 patent”). Fact and expert discovery are…certain claims in patents that cover technology incorporated into the standard. These patents are called ‘…essential patents.’” Id. at 1209. Organizations require owners of standard essential patents to grant…damages analysis. Dr. McDuff’s approach contradicts patent damages law, and his opinions on economic hold-…powder dosage form (which is encompassed by ’996 patent claim 2) or crushed slugs/tablets (in accordance | External link to document | |
| 2019-01-22 | 229 | infringement and damages of United States Patent No. 8,454,996 (“the ’996 patent”). Attached hereto is a…Transcript (excerpt) Exhibit R: U.S. Patent No. 8,454,996 Exhibit S: Dr. Davies’s Opening… 12 December 2019 1:17-cv-00205 830 Patent Plaintiff District Court, D. Delaware | External link to document | |
| 2019-03-12 | 258 | Opinion - Memorandum Opinion | relitigating the validity of U.S. Patent No. 8,454,996 (the "#996 patent"). 1 D.I. 172. The matter… #996 patent. D.I. 1 at ,r,r 47-48, 74-75. Orexo alleges that Teva infringes the #996 patent by manufacturing…Robinson also held that U.S. Patent No. 8,940,330 (the "#330 patent") was invalid as obvious…to the #330 patent implicates Judge Robinson's rulings with respect to the #996 patent. …invalidity of a patent by an alleged infringer is not a 'claim' but a defense to the patent owner&# | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
